 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $20.489,61 | (29/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.195,84 AF $12.293,77 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $15.490,99 |
|
|
|
|
| cr.x 30 g | $40.182,33 | (29/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $16.072,93 AF $24.109,40 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $34.254,08 |
|
|
|
|
| ung.x 15 g | $19.417,79 | (29/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $7.767,12 AF $11.650,67 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $14.419,17 |
|
|
|
|
| ung.x 30 g | $37.216,03 | (29/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $14.886,41 AF $22.329,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $31.287,78 |
|
|
|
|
| |
